A single gene may be involved in a whole range of types of cancer, British researchers revealed last night.
Problems with the gene afflict about one in every 100 cancer patients, researchers found.
Researchers said the gene CUX1 had been found to be inactive in these patients, triggering a biological mechanism that stimulates the growth of tumours.
The problems have been found to be especially common in cancers of the bone marrow – myeloid cancers.
The findings, reported by the Wellcome Trust Sanger Institute, Cambridge, UK, come from a study of more than 7,600 patients involved in the International Cancer Genome Consortium.
Reporting in Nature Genetics, the researchers say they have found several dozen other genes that may have a similar role.
Researcher Dr Chi Wong, a haematologist in Cambridge, said: “Our work harnesses the power of combining large-scale cancer genomics with experimental genetics.
“CUX1 defects are particularly common in myeloid blood cancers, either through mutation or acquired loss of chromosome 7q. As these patients have a dismal prognosis currently, novel targeted therapies are urgently needed.”
Inactivating CUX1 mutations promote tumorigenesis. Nature Genetics 8 Dec 2013; doi: 10.1038/ng.2846

Leave a Reply